PUBLISHER: Grand View Research | PRODUCT CODE: 1888994
PUBLISHER: Grand View Research | PRODUCT CODE: 1888994
U.S. Umbilical Vessel Catheters Market Size, Share & Trends Analysis Report By Product (Umbilical Arterial Catheters, Umbilical Venous Catheters), By Material, By Channel, By Indication/Use, By End Use, And Segment Forecasts, 2025 - 2033
U.S. Umbilical Vessel Catheters Market Summary
The U.S. umbilical vessel catheters market size was estimated at USD 165.39 million in 2024 and is projected to reach USD 258.83 million by 2033, growing at a CAGR of 5.21% from 2025 to 2033. This growth is attributed to the rising prevalence of preterm births and neonatal complications that require immediate vascular access for life-saving interventions.
Growing investments in NICU infrastructure, coupled with the expansion of Level III and Level IV neonatal care units, further strengthen demand for the product. Technological improvements, such as biocompatible materials, kink-resistant designs, and enhanced catheter tip positioning, also enhance adoption. Furthermore, heightened clinical emphasis on infection prevention and safe neonatal vascular access supports the continued use of advanced UVC and UAC systems.
The rising incidence of preterm births is a primary factor driving the growth of the U.S. umbilical vessel catheters industry. Preterm infants often require immediate and reliable vascular access for administering fluids, medications, and parenteral nutrition in neonatal intensive care units (NICUs). Umbilical vessel catheters (UVCs and UACs) play a crucial role in stabilizing these infants during the critical early stages of life. With increasing global preterm birth rates and improved survival outcomes, the demand for advanced, safe, and infection-resistant catheters continues to rise. Moreover, growing awareness among healthcare professionals and the expansion of neonatal care infrastructure further support market growth worldwide. According to the Reproductive Health Journal, the number of preterm births remained high globally, with an estimated 13.4 million cases in 2020. According to the Centers for Disease Control and Prevention (CDC), both early and late preterm birth rates increased by 4% from 2020 to 2021 but later declined by 1%-2% from 2021 to 2022.
The growing need for advanced neonatal intensive care is a major factor driving the U.S. umbilical vessel catheters industry. As the number of preterm and low-birth-weight infants continues to rise, the demand for reliable and safe vascular access solutions has increased significantly. Umbilical vessel catheters play a crucial role in delivering essential medications, fluids, and nutrition while allowing continuous monitoring of critically ill newborns. The expansion of neonatal intensive care units (NICUs) and the adoption of advanced medical technologies are further enhancing their use. In addition, the focus on improving neonatal survival rates and reducing complications is accelerating the adoption of high-performance, infection-resistant catheters across hospitals worldwide.
The expansion of Level III and Level IV neonatal care units is another driver of the U.S. umbilical vessel catheter industry, as these advanced facilities manage the highest volume of premature and critically ill newborns requiring immediate vascular access. As more hospitals upgrade their NICU capabilities, the demand for reliable UVCs and UACs increases to support life-saving interventions, including fluid resuscitation, parenteral nutrition, medication delivery, and continuous monitoring. These units follow stringent clinical protocols that standardize the use of umbilical catheters, ensuring consistent utilization. As investment in specialized neonatal infrastructure increases, the need for high-quality catheters becomes even more crucial in delivering advanced newborn care.
U.S. Umbilical Vessel Catheters Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. umbilical vessel catheters market report based on product, material, channel, indication/use and end use:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Umbilical Arterial Catheters (UACs)
- Umbilical Venous Catheters (UVCs)
- Material Outlook (Revenue, USD Million, 2021 - 2033)
- Polyurethane-based Catheters
- Silicone-based Catheters
- PVC-coated Catheters
- Others
- Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Single Lumen
- Double Lumen
- Triple Lumen
- Indication/Use Outlook (Revenue, USD Million, 2021 - 2033)
- Neonates with Difficult Venous Access (DVA) for Emergency Resuscitation
- Exchange Blood Transfusion
- Cardiac Catheterisation
- Parenteral Nutrition
- Drug Administration
- Frequent Blood Sampling/Arterial Blood Gas Monitoring
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals (NICUs)
- Specialty Clinics or Centers
- Ambulatory Surgery Centers
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Material
- 1.2.3. Channel
- 1.2.4. Indication/Use
- 1.2.5. End Use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.5.5. Information Analysis
- 1.6. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. U.S. Umbilical Vessel Catheters Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising preterm births and neonatal complications
- 3.2.1.2. Expansion of level III and level IV NICUs
- 3.2.1.3. Growing focus on neonatal survival and early intervention
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Risk of catheter-related complications
- 3.2.2.2. Strict regulatory requirements
- 3.2.3. Market Opportunities Analysis
- 3.2.3.1. Growing NICU infrastructure investments
- 3.2.3.2. Technological advancements
- 3.2.4. Market Challenges Analysis
- 3.2.4.1. Maintaining high safety standards
- 3.2.4.2. Short window of use
- 3.2.1. Market Driver Analysis
- 3.3. U.S. Umbilical Vessel Catheters Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
- 3.3.1. Industry Analysis - Porter's
Chapter 4. U.S. Umbilical Vessel Catheters Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. U.S. Umbilical Vessel Catheters Market Product Movement Analysis
- 4.3. U.S. Umbilical Vessel Catheters Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
- 4.4. Umbilical Arterial Catheters (UACs)
- 4.4.1. Umbilical Arterial Catheters (UACs) U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Umbilical Venous Catheters (UVCs)
- 4.5.1. Umbilical Venous Catheters (UVCs) U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Umbilical Vessel Catheters Market: Material Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. U.S. Umbilical Vessel Catheters Market Material Movement Analysis
- 5.3. U.S. Umbilical Vessel Catheters Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
- 5.4. Polyurethane-based Catheters
- 5.4.1. Polyurethane-based Catheters U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Silicone-based Catheters
- 5.5.1. Silicone-based Catheters U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. PVC-coated Catheters
- 5.6.1. PVC-coated Catheters U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Others
- 5.7.1. Others U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Umbilical Vessel Catheters Market: Channel Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. U.S. Umbilical Vessel Catheters Market Channel Movement Analysis
- 6.3. U.S. Umbilical Vessel Catheters Market Size & Trend Analysis, by Channel, 2021 to 2033 (USD Million)
- 6.4. Single Lumen
- 6.4.1. Single Lumen U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Double Lumen
- 6.5.1. Double Lumen U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Triple Lumen
- 6.6.1. Triple Lumen U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Umbilical Vessel Catheters Market: Indication/Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Global Umbilical Vessel Catheters Market Indication/Use Movement Analysis
- 7.3. Global Umbilical Vessel Catheters Market Size & Trend Analysis, by Indication/Use, 2021 to 2033 (USD Million)
- 7.4. Neonates with Difficult Venous Access (DVA) for Emergency Resuscitation
- 7.4.1. Neonates with difficult venous access (DVA) for emergency resuscitation market estimates and forecasts for 2021 to 2033 (USD Million)
- 7.5. Exchange Blood Transfusion
- 7.5.1. Exchange blood transfusion market estimates and forecasts for 2021 to 2033 (USD Million)
- 7.6. Cardiac Catheterisation
- 7.6.1. Cardiac catheterisation market estimates and forecasts for 2021 to 2033 (USD Million)
- 7.7. Parenteral Nutrition
- 7.7.1. Parenteral nutrition market estimates and forecasts for 2021 to 2033 (USD Million)
- 7.8. Drug Administration
- 7.8.1. Drug administration market estimates and forecasts for 2021 to 2033 (USD Million)
- 7.9. Frequent blood sampling/arterial blood gas monitoring
- 7.9.1. Frequent blood sampling/arterial blood gas monitoring market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 8. U.S. Umbilical Vessel Catheters Market: End-Use Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. U.S. Umbilical Vessel Catheters Market End-Use Movement Analysis
- 8.3. U.S. Umbilical Vessel Catheters Market Size & Trend Analysis, by End-Use, 2021 to 2033 (USD Million)
- 8.4. Hospitals (NICUs)
- 8.4.1. Hospitals (NICUs) U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5. Specialty Clinics or Centers
- 8.5.1. Specialty Clinics or Centers U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6. Ambulatory Surgery Centers
- 8.6.1. Ambulatory Surgery Centers U.S. Umbilical Vessel Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.2. Key Company Profiles
- 9.2.1. Vygon
- 9.2.1.1. Company Overview
- 9.2.1.2. Financial Performance
- 9.2.1.3. Material Benchmarking
- 9.2.1.4. Strategic Initiatives
- 9.2.2. Utah Medical Products, Inc.
- 9.2.2.1. Company Overview
- 9.2.2.2. Financial Performance
- 9.2.2.3. Material Benchmarking
- 9.2.2.4. Strategic Initiatives
- 9.2.3. Cardinal Health
- 9.2.3.1. Company Overview
- 9.2.3.2. Financial Performance
- 9.2.3.3. Material Benchmarking
- 9.2.3.4. Strategic Initiatives
- 9.2.4. Laborie
- 9.2.4.1. Company Overview
- 9.2.4.2. Financial Performance
- 9.2.4.3. Material Benchmarking
- 9.2.4.4. Strategic Initiatives
- 9.2.5. AMECATH
- 9.2.5.1. Company Overview
- 9.2.5.2. Financial Performance
- 9.2.5.3. Material Benchmarking
- 9.2.5.4. Strategic Initiatives
- 9.2.6. Neotech Products
- 9.2.6.1. Company Overview
- 9.2.6.2. Financial Performance
- 9.2.6.3. Material Benchmarking
- 9.2.6.4. Strategic Initiatives
- 9.2.1. Vygon
- 9.3. Company Market Share Analysis, 2024
- 9.4. List of Other Key Market Players
List of Tables
- Table 1 List of Secondary Sources
- Table 2 List of Abbreviations
- Table 3 U.S. Umbilical Vessel Catheters Market, by Product, 2021 - 2033 (USD Million)
- Table 4 U.S. Umbilical Vessel Catheters Market, by Material, 2021 - 2033 (USD Million)
- Table 5 U.S. Umbilical Vessel Catheters Market, by Channel, 2021 - 2033 (USD Million)
- Table 6 U.S. Umbilical Vessel Catheters Market, by Indications/Use, 2021 - 2033 (USD Million)
- Table 7 U.S. Umbilical Vessel Catheters Market, by End-Use, 2021 - 2033 (USD Million)
- Table 8 Participant's Overview
- Table 9 Financial Performance
- Table 10 Material Benchmarking
- Table 11 Strategic Initiatives
List of Figures
- Fig. 1 Information Procurement
- Fig. 2 Primary Research Pattern
- Fig. 3 Market Research Approaches
- Fig. 4 Value Chain-Based Sizing & Forecasting
- Fig. 5 Market Formulation & Validation
- Fig. 6 U.S. Umbilical Vessel Catheters Market, Market Segmentation
- Fig. 7 Market Driver Analysis (Current & Future Impact)
- Fig. 8 Market Restraint Analysis (Current & Future Impact)
- Fig. 9 Market Opportunity Analysis (Current & Future Impact)
- Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
- Fig. 11 Porter's Five Forces Analysis
- Fig. 12 Regional Marketplace: Key Takeaways
- Fig. 13 U.S. Umbilical Vessel Catheters Market, for Product, 2021 - 2033 (USD Million)
- Fig. 14 U.S. Umbilical Vessel Catheters Market, for Umbilical Arterial Catheters (UACs), 2021 - 2033 (USD Million)
- Fig. 15 U.S. Umbilical Vessel Catheters Market, for Umbilical Venous Catheters (UVCs), 2021 - 2033 (USD Million)
- Fig. 16 U.S. Umbilical Vessel Catheters Market, for Material, 2021 - 2033 (USD Million)
- Fig. 17 U.S. Umbilical Vessel Catheters Market, for Polyurethane-based Catheters, 2021 - 2033 (USD Million)
- Fig. 18 U.S. Umbilical Vessel Catheters Market, for Silicone-based Catheters, 2021 - 2033 (USD Million)
- Fig. 19 U.S. Umbilical Vessel Catheters Market, for PVC-coated Catheters, 2021 - 2033 (USD Million)
- Fig. 20 U.S. Umbilical Vessel Catheters Market, for Others, 2021 - 2033 (USD Million)
- Fig. 21 U.S. Umbilical Vessel Catheters Market, for Channel, 2021 - 2033 (USD Million)
- Fig. 22 U.S. Umbilical Vessel Catheters Market, for Single Lumen, 2021 - 2033 (USD Million)
- Fig. 23 U.S. Umbilical Vessel Catheters Market, for Double Lumen, 2021 - 2033 (USD Million)
- Fig. 24 U.S. Umbilical Vessel Catheters Market, for Triple Lumen, 2021 - 2033 (USD Million)
- Fig. 25 U.S. Umbilical Vessel Catheters Market, for Indication/Use, 2021 - 2033 (USD Million)
- Fig. 26 U.S. Umbilical Vessel Catheters Market, for Neonates with Difficult Venous Access (DVA) for Emergency Resuscitation, 2021 - 2033 (USD Million)
- Fig. 27 U.S. Umbilical Vessel Catheters Market, for Exchange Blood Transfusion, 2021 - 2033 (USD Million)
- Fig. 28 U.S. Umbilical Vessel Catheters Market, for Cardiac Catheterisation, 2021 - 2033 (USD Million)
- Fig. 29 U.S. Umbilical Vessel Catheters Market, for Drug Administration, 2021 - 2033 (USD Million)
- Fig. 30 U.S. Umbilical Vessel Catheters Market, for Frequent Blood Sampling/Arterial Blood Gas Monitoring, 2021 - 2033 (USD Million)
- Fig. 31 U.S. Umbilical Vessel Catheters Market, for End Use, 2021 - 2033 (USD Million)
- Fig. 32 U.S. Umbilical Vessel Catheters Market, for Hospitals (NICUs), 2021 - 2033 (USD Million)
- Fig. 33 U.S. Umbilical Vessel Catheters Market, for Specialty Clinics or Centers, 2021 - 2033 (USD Million)
- Fig. 34 U.S. Umbilical Vessel Catheters Market, for Ambulatory Surgery Centers, 2021 - 2033 (USD Million)
